EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
This Quarter Return
+17.19%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$2.26B
AUM Growth
+$2.26B
(+20%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
1,083
New
33
Increased
159
Reduced
65
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$42.6M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$15.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.9M |
| 4 |
Westlake Corp
WLK
|
$8.83M |
| 5 |
Booking.com
BKNG
|
$7.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$28.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$20.8M |
| 3 |
TIF
Tiffany & Co.
TIF
|
$9.53M |
| 4 |
iShares Semiconductor ETF
SOXX
|
$7.76M |
| 5 |
Roper Technologies
ROP
|
$5.92M |
Sector Composition
| 1 | Healthcare | 30.5% |
| 2 | Technology | 20.83% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 9.34% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
SPDR S&P 500 ETF Trust
SPY
$658B
| $23.7M | 1.05% | 73,784 +7,800 | +12% | +$2.51M |
|
27
iShares Core S&P 500 ETF
IVV
$662B
| $23.6M | 1.04% | 73,100 +2,200 | +3% | +$711K |
|
28
Mastercard
MA
$538B
| $21.1M | 0.93% | 70,022 +12,642 | +22% | +$3.8M |
|
|
29
Vertex Pharmaceuticals
VRTX
$100B
| $18.1M | 0.8% | 81,900 -130,000 | -61% | -$28.7M |
|
30
Texas Instruments
TXN
$184B
| $17.4M | 0.77% | 135,421 +13,414 | +11% | +$1.72M |
|
31
Amgen
AMGN
$155B
| $16.6M | 0.73% | 68,735 -85 | -0.1% | -$20.5K |
|
32
Illumina
ILMN
$15.8B
| $16.3M | 0.72% | 48,959 +59 | +0.1% | +$19.6K |
|
33
Intel
INTC
$107B
| $16.2M | 0.72% | 269,881 -19,122 | -7% | -$1.15M |
|
34
PepsiCo
PEP
$204B
| $15.8M | 0.7% | 114,610 +8,000 | +8% | +$1.1M |
|
35
Cisco
CSCO
$274B
| $15.5M | 0.69% | 325,088 -24,507 | -7% | -$1.17M |
|
36
Home Depot
HD
$405B
| $14.9M | 0.66% | 67,856 +9,686 | +17% | +$2.13M |
|
37
Intuit
INTU
$186B
| $14.8M | 0.66% | 55,710 +9,643 | +21% | +$2.57M |
|
38
S&P Global
SPGI
$167B
| $14.8M | 0.66% | 54,178 +9,711 | +22% | +$2.66M |
|
39
Procter & Gamble
PG
$368B
| $14.8M | 0.65% | 117,247 +3,326 | +3% | +$419K |
|
40
UnitedHealth
UNH
$281B
| $14.7M | 0.65% | 49,901 -5,912 | -11% | -$1.75M |
|
41
Gilead Sciences
GILD
$140B
| $14.5M | 0.64% | 219,710 -63,745 | -22% | -$4.2M |
|
|
42
Booking.com
BKNG
$181B
| $14.3M | 0.63% | 6,930 +3,490 | +101% | +$7.2M |
|
43
Thermo Fisher Scientific
TMO
$186B
| $13.8M | 0.61% | 42,310 +1,300 | +3% | +$424K |
|
44
Alphabet (Google) Class C
GOOG
$2.58T
| $13.5M | 0.6% | 10,022 +325 | +3% | +$439K |
|
45
NVIDIA
NVDA
$4.24T
| $13.4M | 0.59% | 56,669 +16,699 | +42% | +$3.96M |
|
46
Walt Disney
DIS
$213B
| $13.4M | 0.59% | 91,833 +10,661 | +13% | +$1.55M |
|
47
JPMorgan Chase
JPM
$829B
| $12.9M | 0.57% | 92,490 +4,025 | +5% | +$560K |
|
48
Estee Lauder
EL
$33B
| $12.5M | 0.55% | 60,320 +6,170 | +11% | +$1.28M |
|
49
Nike
NKE
$114B
| $12.5M | 0.55% | 123,100 +3,150 | +3% | +$320K |
|
50
Neurocrine Biosciences
NBIX
$13.8B
| $12.3M | 0.55% | 114,700 +18,000 | +19% | +$1.94M |
|